Bio-Rad Laboratories, Inc. BIO.B Life Science — Cost of goods sold
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s life science — cost of goods sold.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s life science — cost of goods sold?
- Bio-Rad Laboratories, Inc. (BIO.B) reported life science — cost of goods sold of $100.9M in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s life science — cost of goods sold changed year-over-year?
- Bio-Rad Laboratories, Inc.'s life science — cost of goods sold increased by 0.7% year-over-year, from $100.2M to $100.9M.
- What is the long-term trend for Bio-Rad Laboratories, Inc.'s life science — cost of goods sold?
- Over 3 years (2022 to 2025), Bio-Rad Laboratories, Inc.'s life science — cost of goods sold has grown at a -4.2% compound annual growth rate (CAGR), from $532.7M to $468M.
- What does life science — cost of goods sold mean?
- The direct costs associated with manufacturing and delivering the products sold by the Life Science segment.
- How do you interpret life science — cost of goods sold?
- Lower costs relative to sales indicate improved manufacturing efficiency or favorable product mix.
- How does life science — cost of goods sold compare across companies?
- Standard cost accounting metric used to evaluate operational efficiency across the industry.